index,evidence,llm_statement,indra_statement,similarity_rating,llm_explanation,llm_subject,llm_relationship,llm_object,indra_subject,indra_relationship,indra_object,subject_match,relationship_match,object_match,subject_namespace_match,object_namespace_match,match_score,match_type
1,"Recently, metformin, the most widely used first-line drug for diabetes, was found to contain a carcinogenic contaminant known as N-nitroso dimethylamine (NDMA).","a(CHEBI:metformin) hasComponent a(CHEBI:N,N-dimethyl-4-nitrosoaniline)",,,,a(CHEBI:metformin),hasComponent,"a(CHEBI:N,N-dimethyl-4-nitrosoaniline)",,,,False,False,False,False,False,0.0,LLM Only
3,"Phosphorylation at S326 is mediated by AKT1, mTOR, p38, MEK1 and DYRK2.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,"act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,False,False,False,False,False,0.0,LLM Only
3,AKT2 also phosphorylated S326 of HSF1 but showed weak ability to activate HSF1.,"act(p(HGNC:AKT2), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))","p(HGNC:392 ! AKT2) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Good,"Both statements describe the same biological event where AKT2 kinase activity leads to the phosphorylation of HSF1 at Serine 326. The only difference is in the way the phosphorylation is represented, but it does not change the biological meaning.","act(p(HGNC:AKT2), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT2),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,True,True,True,0.7710227272727274,Best Match
3,"Similarly, mTOR, p38, MEK1 and DYRK2 all phosphorylated S326 but AKT1 was the most potent activator.","act(p(HGNC:MTOR), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,"act(p(HGNC:MTOR), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,False,False,False,False,False,0.0,LLM Only
3,"Similarly, mTOR, p38, MEK1 and DYRK2 all phosphorylated S326 but AKT1 was the most potent activator.","act(p(HGNC:MAP2K1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,"act(p(HGNC:MAP2K1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,False,False,False,False,False,0.0,LLM Only
3,"Similarly, mTOR, p38, MEK1 and DYRK2 all phosphorylated S326 but AKT1 was the most potent activator.","act(p(HGNC:DYRK2), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,"act(p(HGNC:DYRK2), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,False,False,False,False,False,0.0,LLM Only
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 142))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",Good,"Both statements describe the same biological event where AKT1 kinase activity leads to the phosphorylation of HSF1 at Threonine 142. The only difference is in the way protein phosphorylation is represented, but it does not change the biological meaning.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 142))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",False,True,True,True,True,0.7710227272727274,Best Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 142))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",Medium,"Both statements indicate that AKT1 directly increases the phosphorylation of HSF1. However, the phosphorylation site is different in each statement (Thr142 vs Thr527), which could potentially lead to different biological outcomes.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 142))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",False,True,False,True,True,0.6645833333333334,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 142))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1. However, the modification sites and types are different: the LLM statement mentions a phosphorylation at Threonine 142, while the INDRA statement mentions a phosphorylation at Serine 326.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 142))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,False,True,True,0.6591346153846154,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 142))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1. However, the post-translational modifications (pmod) differ in the type of residue and the position of the modification (Thr 142 in the LLM statement vs Ser 230 in the INDRA statement).","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 142))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",False,True,False,True,True,0.6591346153846154,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 230))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",Good,"Both statements describe the same biological event where the protein AKT1 increases the phosphorylation of the protein HSF1 at serine 230. The only difference is in the way the phosphorylation process is described, but it does not change the biological meaning.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 230))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",False,True,True,True,True,0.7710227272727274,Best Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 230))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements describe a similar biological event where AKT1 increases the phosphorylation of HSF1. However, the phosphorylation site differs between the two statements (Ser230 vs Ser326), which could potentially lead to different biological outcomes.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 230))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,False,True,True,0.6645833333333334,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 230))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1. However, the post-translational modifications (pmod) differ in the type of residue and the position, with the LLM statement indicating phosphorylation at Serine 230 and the INDRA statement indicating phosphorylation at Threonine 527.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 230))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",False,True,False,True,True,0.6591346153846154,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 230))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1. However, the post-translational modifications (pmod) are different in terms of the type of modification and the position of the modification on the protein, which can significantly affect the function of the protein.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 230))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",False,True,False,True,True,0.6591346153846154,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 527))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",Good,"Both statements describe the same biological event where the protein AKT1 increases the phosphorylation of the protein HSF1 at Threonine 527. The only difference is in the way the phosphorylation process is described, but it does not change the biological meaning.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 527))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",False,True,True,True,True,0.7710227272727274,Best Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 527))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",Medium,"Both statements describe a similar biological event where AKT1 increases the phosphorylation of HSF1. However, the phosphorylation site differs between the two statements (Thr527 vs Thr142), which can significantly impact the biological function of HSF1.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 527))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",False,True,False,True,True,0.6645833333333334,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 527))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements indicate that AKT1 directly increases the phosphorylation of HSF1. However, the phosphorylation sites and types are different: the LLM statement mentions phosphorylation at Threonine 527, while the INDRA statement mentions phosphorylation at Serine 326.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 527))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,False,True,True,0.6591346153846154,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 527))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",Medium,"Both statements indicate that AKT1 directly increases the phosphorylation of HSF1. However, the phosphorylation sites and types are different: Threonine 527 in the LLM statement versus Serine 230 in the INDRA statement.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 527))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",False,True,False,True,True,0.6591346153846154,Secondary Match
4,We previously identified AKT1 as an upstream regulator of HSF1 activity via phosphorylation of HSF1 at S326.,"act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,"act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,False,False,False,False,False,0.0,LLM Only
4,"Consistent with our previous findings, AKT1 strongly induced HSF1 activity (Fig. 1A-C).",act(p(HGNC:AKT1)) directlyIncreases act(p(HGNC:HSF1)),,,,act(p(HGNC:AKT1)),directlyIncreases,act(p(HGNC:HSF1)),,,,False,False,False,False,False,0.0,LLM Only
4,"AKT2 promoted a significant increase in HSF1 activity, but the effect was modest while AKT3 had no significant effect on HSF1 activity (Fig. 1A-C).",act(p(HGNC:AKT2)) increases act(p(HGNC:HSF1)),,,,act(p(HGNC:AKT2)),increases,act(p(HGNC:HSF1)),,,,False,False,False,False,False,0.0,LLM Only
4,Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).,"act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Good,"Both statements describe the same biological event where AKT1 kinase activity leads to the phosphorylation of HSF1 at Serine 326. The only difference is in the way protein phosphorylation is represented, but it does not change the biological meaning.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,True,True,True,0.7710227272727274,Best Match
4,Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).,"act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))","p(HGNC:392 ! AKT2) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements describe a similar biological event where AKT increases the phosphorylation of HSF1 at Serine 326. However, the subject in the first statement is AKT1, while in the second statement it is AKT2. These are different isoforms of AKT, which may have different biological effects.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT2),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,True,True,True,0.7633838383838384,Secondary Match
4,Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).,"act(p(HGNC:AKT2), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))","p(HGNC:392 ! AKT2) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Good,"Both statements describe the same biological event where AKT2 kinase activity leads to the phosphorylation of HSF1 at Serine 326. The only difference is in the way phosphorylation is represented, but it does not change the biological meaning.","act(p(HGNC:AKT2), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT2),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,True,True,True,0.7710227272727274,Best Match
4,Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).,"act(p(HGNC:AKT2), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements describe a similar biological event where AKT protein increases the phosphorylation of HSF1 at Serine 326. However, the LLM statement refers to AKT2 while the INDRA statement refers to AKT1, which are different isoforms of the AKT protein.","act(p(HGNC:AKT2), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,True,True,True,0.7633838383838384,Secondary Match
5,"These results seem contradictory because AKT2 phosphorylated S326, but the level of phosphorylation far exceeded the HSF1 activity induced by AKT2 (Fig. 1A-D).","act(p(HGNC:AKT2), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:392 ! AKT2) increases p(HGNC:5224 ! HSF1),Medium,"Both statements involve AKT2 increasing HSF1. However, the LLM statement specifies that AKT2 is acting with kinase activity and directly increases a phosphorylated form of HSF1 at Serine 326, while the INDRA statement does not provide these details.","act(p(HGNC:AKT2), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT2),increases,p(HGNC:HSF1),False,False,False,True,True,0.2651785714285714,Best Match
5,AKT1 is also a well-known activator of mTOR and mTOR has been shown to phosphorylate HSF1 at S326 in response to proteotoxic stress.,"act(p(HGNC:MTOR), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,"act(p(HGNC:MTOR), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,False,False,False,False,False,0.0,LLM Only
6,"Introduction of AKT1 was observed to promote a significant increase in trimerization, although the AKT1-driven trimerization was not as much as heat stress (Fig. 2A-B).",p(HGNC:AKT1) increases complex(p(HGNC:HSF1)),,,,p(HGNC:AKT1),increases,complex(p(HGNC:HSF1)),,,,False,False,False,False,False,0.0,LLM Only
6,"Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).",p(HGNC:AKT1) increases p(HGNC:HSF1),,,,p(HGNC:AKT1),increases,p(HGNC:HSF1),,,,False,False,False,False,False,0.0,LLM Only
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",p(HGNC:AKT1) increases r(HGNC:HSPA1A),p(HGNC:391 ! AKT1) increases p(FPLX:HSP90 ! HSP90),Medium,"The subject of both statements is the same, AKT1. However, the objects are different: HSPA1A in the first statement and HSP90 in the second. Although both objects are heat shock proteins, they are not identical, hence the medium similarity rating.",p(HGNC:AKT1),increases,r(HGNC:HSPA1A),p(HGNC:AKT1),increases,p(FPLX:HSP90),True,True,False,True,False,0.7000000000000001,Best Match
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",p(HGNC:AKT1) increases r(HGNC:HSPA1A),p(HGNC:391 ! AKT1) increases p(FPLX:HSPA ! HSPA),Medium,"The two statements are similar in that they both describe an increase in activity caused by AKT1. However, the target in the first statement is a specific gene (HSPA1A), while the target in the second statement is a family of proteins (HSPA), which includes HSPA1A but also other proteins.",p(HGNC:AKT1),increases,r(HGNC:HSPA1A),p(HGNC:AKT1),increases,p(FPLX:HSPA),True,True,False,True,False,0.7000000000000001,Secondary Match
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",p(HGNC:AKT1) increases r(HGNC:HSPA1A),p(HGNC:392 ! AKT2) increases p(FPLX:HSP90 ! HSP90),Medium,"The two statements are somewhat similar as they both describe an increase relationship between two proteins. However, the subject proteins are different (AKT1 vs AKT2) and the object proteins are also different but belong to the same family (HSPA1A vs HSP90).",p(HGNC:AKT1),increases,r(HGNC:HSPA1A),p(HGNC:AKT2),increases,p(FPLX:HSP90),False,True,False,True,False,0.5750000000000001,Secondary Match
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",p(HGNC:AKT1) increases r(HGNC:HSPA1A),p(HGNC:392 ! AKT2) increases p(FPLX:HSPA ! HSPA),Medium,"The two statements are somewhat similar as they both describe an increase relationship between two proteins. However, the subject in the first statement is AKT1, while in the second statement it is AKT2. Similarly, the object in the first statement is HSPA1A, while in the second statement it is HSPA, which is a family of proteins that includes HSPA1A.",p(HGNC:AKT1),increases,r(HGNC:HSPA1A),p(HGNC:AKT2),increases,p(FPLX:HSPA),False,True,False,True,False,0.5750000000000001,Secondary Match
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",p(HGNC:AKT1) increases r(HGNC:HSPA1A),p(HGNC:393 ! AKT3) increases p(FPLX:HSP90 ! HSP90),Medium,"The two statements are somewhat similar as they both describe an increase in activity caused by a protein in the AKT family. However, they differ in the specific AKT protein (AKT1 vs AKT3) and the target protein (HSPA1A vs HSP90).",p(HGNC:AKT1),increases,r(HGNC:HSPA1A),p(HGNC:AKT3),increases,p(FPLX:HSP90),False,True,False,True,False,0.5750000000000001,Secondary Match
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",p(HGNC:AKT1) increases r(HGNC:HSPA1A),p(HGNC:393 ! AKT3) increases p(FPLX:HSPA ! HSPA),Medium,"The two statements are somewhat similar as they both describe an increase relationship between two proteins. However, the subject proteins are different (AKT1 vs AKT3) and the object in the second statement is a family of proteins (HSPA) rather than a specific one (HSPA1A).",p(HGNC:AKT1),increases,r(HGNC:HSPA1A),p(HGNC:AKT3),increases,p(FPLX:HSPA),False,True,False,True,False,0.5750000000000001,Secondary Match
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",p(HGNC:AKT1) increases r(HGNC:HSPA8),p(HGNC:391 ! AKT1) increases p(FPLX:HSP90 ! HSP90),Medium,"The subject of both statements is the same, AKT1, and the relationship is also the same, 'increases'. However, the objects are different: HSPA8 in the first statement and HSP90 in the second. Both HSPA8 and HSP90 are heat shock proteins, but they are not the same, hence the 'Medium' rating.",p(HGNC:AKT1),increases,r(HGNC:HSPA8),p(HGNC:AKT1),increases,p(FPLX:HSP90),True,True,False,True,False,0.7000000000000001,Best Match
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",p(HGNC:AKT1) increases r(HGNC:HSPA8),p(HGNC:391 ! AKT1) increases p(FPLX:HSPA ! HSPA),Medium,"The subject of both statements is the same, AKT1. However, the object in the LLM statement is a specific gene product of HSPA8, while the object in the INDRA statement is the HSPA family. This difference in specificity of the object leads to a medium similarity rating.",p(HGNC:AKT1),increases,r(HGNC:HSPA8),p(HGNC:AKT1),increases,p(FPLX:HSPA),True,True,False,True,False,0.7000000000000001,Secondary Match
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",p(HGNC:AKT1) increases r(HGNC:HSPA8),p(HGNC:392 ! AKT2) increases p(FPLX:HSP90 ! HSP90),Medium,"The two statements are somewhat similar as they both describe an increase in activity caused by a protein in the AKT family. However, they differ in the specific AKT protein (AKT1 vs AKT2) and the specific heat shock protein (HSPA8 vs HSP90).",p(HGNC:AKT1),increases,r(HGNC:HSPA8),p(HGNC:AKT2),increases,p(FPLX:HSP90),False,True,False,True,False,0.5750000000000001,Secondary Match
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",p(HGNC:AKT1) increases r(HGNC:HSPA8),p(HGNC:392 ! AKT2) increases p(FPLX:HSPA ! HSPA),Medium,"The two statements are somewhat similar as they both describe an increase relationship between two proteins. However, the subject proteins are different (AKT1 vs AKT2) and the object in the second statement is a family of proteins (HSPA) rather than a specific one (HSPA8).",p(HGNC:AKT1),increases,r(HGNC:HSPA8),p(HGNC:AKT2),increases,p(FPLX:HSPA),False,True,False,True,False,0.5750000000000001,Secondary Match
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",p(HGNC:AKT1) increases r(HGNC:HSPA8),p(HGNC:393 ! AKT3) increases p(FPLX:HSP90 ! HSP90),Medium,"The two statements are somewhat similar as they both describe an increase in activity caused by a protein in the AKT family. However, they differ in the specific AKT protein (AKT1 vs AKT3) and the specific heat shock protein (HSPA8 vs HSP90).",p(HGNC:AKT1),increases,r(HGNC:HSPA8),p(HGNC:AKT3),increases,p(FPLX:HSP90),False,True,False,True,False,0.5750000000000001,Secondary Match
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",p(HGNC:AKT1) increases r(HGNC:HSPA8),p(HGNC:393 ! AKT3) increases p(FPLX:HSPA ! HSPA),Medium,"The two statements are similar in that they both describe an increase relationship between two proteins. However, the subject proteins are different (AKT1 vs AKT3) and the object in the second statement is a protein family (HSPA), not a specific protein (HSPA8).",p(HGNC:AKT1),increases,r(HGNC:HSPA8),p(HGNC:AKT3),increases,p(FPLX:HSPA),False,True,False,True,False,0.5750000000000001,Secondary Match
8,"Effects of tripterine were investigated on endothelial barrier function, inducible nitric oxide synthase (iNOS) expression, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, 3-nitrotyrosine formation, protein phosphatase type 2A (PP2A) activity, activation of extracellular-regulated kinase (ERK), c-Jun terminal kinase (JNK) and Janus kinase (Jak2), and degradation of IkB in microvascular endothelial cells exposed to pro-inflammatory stimulus [lipopolysaccharide (LPS) + interferon g (IFNg)] and on vascular permeability in air pouches of mice injected with LPS + IFNg.",a(CHEBI:celastrol) decreases p(HGNC:NOS2),,,,a(CHEBI:celastrol),decreases,p(HGNC:NOS2),,,,False,False,False,False,False,0.0,LLM Only
8,"Effects of tripterine were investigated on endothelial barrier function, inducible nitric oxide synthase (iNOS) expression, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, 3-nitrotyrosine formation, protein phosphatase type 2A (PP2A) activity, activation of extracellular-regulated kinase (ERK), c-Jun terminal kinase (JNK) and Janus kinase (Jak2), and degradation of IkB in microvascular endothelial cells exposed to pro-inflammatory stimulus [lipopolysaccharide (LPS) + interferon g (IFNg)] and on vascular permeability in air pouches of mice injected with LPS + IFNg.",a(CHEBI:celastrol) decreases act(a(CHEBI:NADPH)),,,,a(CHEBI:celastrol),decreases,act(a(CHEBI:NADPH)),,,,False,False,False,False,False,0.0,LLM Only
8,"Effects of tripterine were investigated on endothelial barrier function, inducible nitric oxide synthase (iNOS) expression, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, 3-nitrotyrosine formation, protein phosphatase type 2A (PP2A) activity, activation of extracellular-regulated kinase (ERK), c-Jun terminal kinase (JNK) and Janus kinase (Jak2), and degradation of IkB in microvascular endothelial cells exposed to pro-inflammatory stimulus [lipopolysaccharide (LPS) + interferon g (IFNg)] and on vascular permeability in air pouches of mice injected with LPS + IFNg.",a(CHEBI:celastrol) decreases act(p(HGNC:JAK2)),,,,a(CHEBI:celastrol),decreases,act(p(HGNC:JAK2)),,,,False,False,False,False,False,0.0,LLM Only
9,"The second phase, excision of a short DNA strand segment containing the lesion, is carried out by an assembly of the XPG and XPF:excision repair cross-complementing 1 (ERCC1) endonucleases, together with XPA, RPA, TFIIH, and PCNA (which can bind XPG).","complex(p(HGNC:ERCC5), p(HGNC:ERCC4), p(HGNC:ERCC1), p(HGNC:XPA), p(HGNC:GTF2H3), p(HGNC:PCNA))",,,,"complex(p(HGNC:ERCC5), p(HGNC:ERCC4), p(HGNC:ERCC1), p(HGNC:XPA), p(HGNC:GTF2H3), p(HGNC:PCNA))",,,,,,False,False,False,False,False,0.0,LLM Only
11,"Kinases DYRK1A and DYRK3 have been shown to phosphorylate human SIRT1 at T522, stimulating the deacetylation of p53 by SIRT1; phosphorylation at this site increases the rate of product release by SIRT1.","act(p(HGNC:DYRK1A), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:SIRT1, pmod(Ph, Thr, 522))","p(HGNC:14929 ! SIRT1) directlyDecreases p(HGNC:11998 ! TP53, pmod(go:0006473 ! ""protein acetylation""))",Bad,"The two statements are quite different both in terms of the proteins involved and the relationships described. The first statement describes DYRK1A increasing the phosphorylation of SIRT1, while the second statement describes SIRT1 decreasing the acetylation of TP53.","act(p(HGNC:DYRK1A), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:SIRT1, pmod(Ph, Thr, 522))",p(HGNC:SIRT1),directlyDecreases,"p(HGNC:TP53, pmod(go:0006473 ! ""protein acetylation""))",False,False,False,True,True,0.2486111111111111,Best Match
11,"Kinases DYRK1A and DYRK3 have been shown to phosphorylate human SIRT1 at T522, stimulating the deacetylation of p53 by SIRT1; phosphorylation at this site increases the rate of product release by SIRT1.","act(p(HGNC:DYRK3), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:SIRT1, pmod(Ph, Thr, 522))","p(HGNC:14929 ! SIRT1) directlyDecreases p(HGNC:11998 ! TP53, pmod(go:0006473 ! ""protein acetylation""))",Bad,"The two statements are quite different in their biological meaning. The first statement describes DYRK3 increasing the phosphorylation of SIRT1, while the second statement describes SIRT1 decreasing the acetylation of TP53. The subjects, objects, and relationships are all different.","act(p(HGNC:DYRK3), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:SIRT1, pmod(Ph, Thr, 522))",p(HGNC:SIRT1),directlyDecreases,"p(HGNC:TP53, pmod(go:0006473 ! ""protein acetylation""))",False,False,False,True,True,0.2486111111111111,Best Match
11,"Sumoylation at K734 by SUMO1 increases, whereas desumoylation by SENP1 decreases, the activity of SIRT1 in response to genotoxic stress.","act(p(HGNC:SUMO1), ma(GO:""SUMO transferase activity"")) directlyIncreases act(p(HGNC:SIRT1))",,,,"act(p(HGNC:SUMO1), ma(GO:""SUMO transferase activity""))",directlyIncreases,act(p(HGNC:SIRT1)),,,,False,False,False,False,False,0.0,LLM Only
11,"Sumoylation at K734 by SUMO1 increases, whereas desumoylation by SENP1 decreases, the activity of SIRT1 in response to genotoxic stress.","act(p(HGNC:SENP1), ma(GO:""protein desumoylation"")) directlyDecreases act(p(HGNC:SIRT1))",,,,"act(p(HGNC:SENP1), ma(GO:""protein desumoylation""))",directlyDecreases,act(p(HGNC:SIRT1)),,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",p(HGNC:SIRT1) loc(GO:nucleus),,,,p(HGNC:SIRT1) loc(GO:nucleus),,,,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",p(HGNC:SIRT6) loc(GO:nucleus),,,,p(HGNC:SIRT6) loc(GO:nucleus),,,,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",p(HGNC:SIRT7) loc(GO:nucleus),,,,p(HGNC:SIRT7) loc(GO:nucleus),,,,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",p(HGNC:SIRT2) loc(GO:cytoplasm),,,,p(HGNC:SIRT2) loc(GO:cytoplasm),,,,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",p(HGNC:SIRT3) loc(GO:mitochondrion),,,,p(HGNC:SIRT3) loc(GO:mitochondrion),,,,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",p(HGNC:SIRT4) loc(GO:mitochondrion),,,,p(HGNC:SIRT4) loc(GO:mitochondrion),,,,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",p(HGNC:SIRT5) loc(GO:mitochondrion),,,,p(HGNC:SIRT5) loc(GO:mitochondrion),,,,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.","act(p(HGNC:SIRT1), ma(GO:""deacetylase activity""))",,,,"act(p(HGNC:SIRT1), ma(GO:""deacetylase activity""))",,,,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.","act(p(HGNC:SIRT5), ma(GO:""deacetylase activity""))",,,,"act(p(HGNC:SIRT5), ma(GO:""deacetylase activity""))",,,,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.","act(p(HGNC:SIRT4), ma(GO:""ADP-ribosyltransferase activity""))",,,,"act(p(HGNC:SIRT4), ma(GO:""ADP-ribosyltransferase activity""))",,,,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.","act(p(HGNC:SIRT6), ma(GO:""ADP-ribosyltransferase activity""))",,,,"act(p(HGNC:SIRT6), ma(GO:""ADP-ribosyltransferase activity""))",,,,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.","act(p(HGNC:SIRT2), ma(GO:""deacetylase activity""))",,,,"act(p(HGNC:SIRT2), ma(GO:""deacetylase activity""))",,,,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.","act(p(HGNC:SIRT2), ma(GO:""ADP-ribosyltransferase activity""))",,,,"act(p(HGNC:SIRT2), ma(GO:""ADP-ribosyltransferase activity""))",,,,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.","act(p(HGNC:SIRT3), ma(GO:""deacetylase activity""))",,,,"act(p(HGNC:SIRT3), ma(GO:""deacetylase activity""))",,,,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.","act(p(HGNC:SIRT3), ma(GO:""ADP-ribosyltransferase activity""))",,,,"act(p(HGNC:SIRT3), ma(GO:""ADP-ribosyltransferase activity""))",,,,,,False,False,False,False,False,0.0,LLM Only
12,This review will focus on SIRT1 (EC 3.5.1.-) a member of the sirtuin family that is expressed in many tissues and acts as a NAD+-dependent protein deacetylase.,"act(p(HGNC:SIRT1), ma(GO:""deacetylase activity""))",,,,"act(p(HGNC:SIRT1), ma(GO:""deacetylase activity""))",,,,,,False,False,False,False,False,0.0,LLM Only
13,"NF-kappaB signaling exerts anti-apoptotic and cyto-protective properties, which is illustrated by many genetic in vivo models, in which deficiency of central pathway constituents, such as TAK1, IKKss, and IKKgamma induced massive hepatocellular cell death (Luedde and Schwabe,).","p(HGNC:MAP3K7) decreases bp(GO:""apoptotic process"")",,,,p(HGNC:MAP3K7),decreases,"bp(GO:""apoptotic process"")",,,,False,False,False,False,False,0.0,LLM Only
13,"NF-kappaB signaling exerts anti-apoptotic and cyto-protective properties, which is illustrated by many genetic in vivo models, in which deficiency of central pathway constituents, such as TAK1, IKKss, and IKKgamma induced massive hepatocellular cell death (Luedde and Schwabe,).","p(HGNC:IKBKG) decreases bp(GO:""apoptotic process"")",,,,p(HGNC:IKBKG),decreases,"bp(GO:""apoptotic process"")",,,,False,False,False,False,False,0.0,LLM Only
13,"Interestingly, previous experiments demonstrated that TNF activated NF-kappaB and JNK signaling with different dynamics (Iqbal and Zaidi,)",p(HGNC:TNF) increases p(FPLX:NFkappaB),p(HGNC:11892 ! TNF) increases p(FPLX:NFkappaB ! NFkappaB),Good,"Both statements are identical in their biological meaning, indicating that the protein TNF increases the protein NFkappaB. The only difference is the notation used to identify the TNF protein, but both refer to the same entity.",p(HGNC:TNF),increases,p(FPLX:NFkappaB),p(HGNC:TNF),increases,p(FPLX:NFkappaB),True,True,True,True,True,1.0,Best Match
13,"Interestingly, previous experiments demonstrated that TNF activated NF-kappaB and JNK signaling with different dynamics (Iqbal and Zaidi,)",p(HGNC:TNF) increases p(FPLX:NFkappaB),p(HGNC:11892 ! TNF) increases p(FPLX:JNK ! JNK),Medium,"Both statements involve the protein TNF as the subject and describe an increase in activity. However, the objects of the statements are different, with the LLM statement involving NFkappaB and the INDRA statement involving JNK.",p(HGNC:TNF),increases,p(FPLX:NFkappaB),p(HGNC:TNF),increases,p(FPLX:JNK),True,True,False,True,True,0.8750000000000001,Secondary Match
14,"Biological functions of TNF and subsequent activation of the NF-kappaB signaling pathway are associated with inflammatory processes, hepatocyte proliferation in response to acute or chronic liver damage, as well as tumorigenesis (DiDonato et al.,).",p(HGNC:TNF) increases bp(GO:hepatocyte proliferation),"p(HGNC:11892 ! TNF) increases bp(GO:""GO:0007165"" ! ""signal transduction"")",Bad,"The two statements are quite different in their biological meaning. The first statement suggests that the protein TNF increases hepatocyte proliferation, while the second statement suggests that the same protein increases signal transduction. These are two different biological processes.",p(HGNC:TNF),increases,bp(GO:hepatocyte proliferation),p(HGNC:TNF),increases,"bp(GO:""GO:0007165"" ! ""signal transduction"")",True,True,False,True,True,0.8642857142857143,Best Match
14,"Biological functions of TNF and subsequent activation of the NF-kappaB signaling pathway are associated with inflammatory processes, hepatocyte proliferation in response to acute or chronic liver damage, as well as tumorigenesis (DiDonato et al.,).",p(HGNC:TNF) increases bp(GO:hepatocyte proliferation),p(HGNC:11892 ! TNF) increases p(FPLX:NFkappaB ! NFkappaB),Bad,"The two statements are quite different. The first statement suggests that TNF protein increases hepatocyte proliferation, while the second statement suggests that TNF protein increases NFkappaB protein. The subjects are the same but the objects and their biological implications are different.",p(HGNC:TNF),increases,bp(GO:hepatocyte proliferation),p(HGNC:TNF),increases,p(FPLX:NFkappaB),True,True,False,True,False,0.7000000000000001,Secondary Match
15,A20 suppresses apoptotic JNK signaling in a TNF-dependent and independent manner via induction of ASK1 degradation.,p(HGNC:TNFAIP3) directlyDecreases act(p(HGNC:MAP3K5)),p(FPLX:JNK ! JNK) increases p(HGNC:11892 ! TNF),Bad,"The two statements are not similar. The first statement indicates that TNFAIP3 protein decreases the activity of MAP3K5 protein, while the second statement suggests that JNK protein increases the TNF protein. The proteins involved and the relationships between them are different in both statements.",p(HGNC:TNFAIP3),directlyDecreases,act(p(HGNC:MAP3K5)),p(FPLX:JNK),increases,p(HGNC:TNF),False,False,False,False,True,0.18,Best Match
15,ASK1 can phosphorylate JNK and the physical interaction between A20 and ASK1 has been demonstrated.,p(HGNC:MAP3K5) directlyIncreases act(p(FPLX:JNK)),"p(HGNC:6857 ! MAP3K5) directlyIncreases p(FPLX:JNK ! JNK, pmod(go:0006468 ! ""protein phosphorylation""))",Good,"Both statements describe the same biological event where MAP3K5 protein increases the activity of JNK protein. The INDRA statement additionally specifies the process as protein phosphorylation, but this does not change the overall meaning.",p(HGNC:MAP3K5),directlyIncreases,act(p(FPLX:JNK)),p(HGNC:MAP3K5),directlyIncreases,"p(FPLX:JNK, pmod(go:0006468 ! ""protein phosphorylation""))",True,True,False,True,True,0.8666666666666668,Best Match
16,"Once the C1 complex is bound to the cell surface, the proteases are activated and are able to cleave another complement protein, C4 into the anaphylatoxin C4a and C4b.","complex(p(FPLX:C1q), p(HGNC:C1R), p(HGNC:C1R), p(HGNC:C1S), p(HGNC:C1S)) directlyIncreases act(p(HGNC:C4A), ma(GO:""serine-type endopeptidase activity""))",,,,"complex(p(FPLX:C1q), p(HGNC:C1R), p(HGNC:C1R), p(HGNC:C1S), p(HGNC:C1S))",directlyIncreases,"act(p(HGNC:C4A), ma(GO:""serine-type endopeptidase activity""))",,,,False,False,False,False,False,0.0,LLM Only
16,"This cleavage causes a large conformational change in C4b, allowing it to covalently bind to cell surfaces and bind another complement protein, C2.","p(HGNC:C4B) directlyIncreases complex(p(HGNC:C4B), p(HGNC:C2))",,,,p(HGNC:C4B),directlyIncreases,"complex(p(HGNC:C4B), p(HGNC:C2))",,,,False,False,False,False,False,0.0,LLM Only
16,"The complex of C4b and C2a (C4b2a) is a serine protease that specifically cleaves C3 into the anaphylatoxin C3a and the active form of C3, C3b, which is then able to covalently bind to the cell surfaces.","complex(p(HGNC:C4B), p(HGNC:C2)) directlyIncreases act(p(HGNC:C3), ma(GO:""serine-type endopeptidase activity""))",,,,"complex(p(HGNC:C4B), p(HGNC:C2))",directlyIncreases,"act(p(HGNC:C3), ma(GO:""serine-type endopeptidase activity""))",,,,False,False,False,False,False,0.0,LLM Only
17,"Once bound to see C3b, factor H serves as a co-factor, allowing another compliment protein, factor I, to cleave C3b, thus inactivating it.",p(HGNC:CFH) directlyIncreases a(CHEBI:cofactor),,,,p(HGNC:CFH),directlyIncreases,a(CHEBI:cofactor),,,,False,False,False,False,False,0.0,LLM Only
18,Li and coworkers demonstrated that partial sciatic nerve ligation activated complement.,"act(p(HGNC:C3)) increases bp(GO:""complement activation"")",,,,act(p(HGNC:C3)),increases,"bp(GO:""complement activation"")",,,,False,False,False,False,False,0.0,LLM Only
18,"After ligation, C3 deposition was seen at the injury site, as well as in areas near the injury site, while no deposition was seen on sham-operated animals (no partial ligation).",act(p(HGNC:C3)) increases a(HGNC:C3),,,,act(p(HGNC:C3)),increases,a(HGNC:C3),,,,False,False,False,False,False,0.0,LLM Only
18,Activation of complement also increased the influx of macrophages.,"act(p(HGNC:C3)) increases bp(GO:""macrophage infiltration"")",,,,act(p(HGNC:C3)),increases,"bp(GO:""macrophage infiltration"")",,,,False,False,False,False,False,0.0,LLM Only
19,"In this study, we report that SLAMF1 is required for Toll-like receptor 4 (TLR4)-mediated induction of interferon beta (IFNbeta) and for killing of Gram-negative bacteria by human macrophages.",p(HGNC:SLAMF1) directlyIncreases p(HGNC:TLR4),p(HGNC:11850 ! TLR4) increases p(HGNC:11850 ! TLR4),Bad,"The two statements are not similar. The LLM statement suggests that SLAMF1 protein increases TLR4 protein, while the INDRA statement suggests that TLR4 protein increases itself, which is a different biological concept.",p(HGNC:SLAMF1),directlyIncreases,p(HGNC:TLR4),p(HGNC:TLR4),increases,p(HGNC:TLR4),False,False,True,True,True,0.47500000000000003,Best Match
19,"In this study, we report that SLAMF1 is required for Toll-like receptor 4 (TLR4)-mediated induction of interferon beta (IFNbeta) and for killing of Gram-negative bacteria by human macrophages.",p(HGNC:SLAMF1) directlyIncreases p(HGNC:TLR4),p(HGNC:11850 ! TLR4) increases p(HGNC:5434 ! IFNB1),Bad,"The two statements are quite different in their biological meaning. The first statement suggests that SLAMF1 protein increases TLR4 protein, while the second statement suggests that TLR4 protein increases IFNB1 protein. The subjects, objects, and relationships are all different.",p(HGNC:SLAMF1),directlyIncreases,p(HGNC:TLR4),p(HGNC:TLR4),increases,p(HGNC:IFNB1),False,False,False,True,True,0.35000000000000003,Secondary Match
19,We found that SLAMF1 controls trafficking of the Toll receptor-associated molecule (TRAM) from the endocytic recycling compartment (ERC) to Escherichia coli phagosomes.,p(HGNC:SLAMF1) directlyIncreases p(HGNC:TICAM2),"p(HGNC:10903 ! SLAMF1) partOf complex(p(HGNC:10903 ! SLAMF1), p(HGNC:20568 ! TRAM1))",Bad,"The two statements are quite different. The LLM statement suggests that SLAMF1 directly increases TICAM2, while the INDRA statement indicates that SLAMF1 is part of a complex with TRAM1. There is no overlap in the relationships or the objects involved in these statements.",p(HGNC:SLAMF1),directlyIncreases,p(HGNC:TICAM2),p(HGNC:SLAMF1),partOf,"complex(p(HGNC:SLAMF1), p(HGNC:TRAM1))",True,False,False,True,True,0.4666666666666667,Best Match
19,We found that SLAMF1 controls trafficking of the Toll receptor-associated molecule (TRAM) from the endocytic recycling compartment (ERC) to Escherichia coli phagosomes.,p(HGNC:SLAMF1) directlyIncreases p(HGNC:TICAM2),"p(HGNC:20568 ! TRAM1) partOf complex(p(HGNC:10903 ! SLAMF1), p(HGNC:20568 ! TRAM1))",Bad,"The two statements are quite different. The LLM statement suggests that SLAMF1 protein directly increases the TICAM2 protein, while the INDRA statement indicates that TRAM1 protein is part of a complex with SLAMF1 protein. There is no overlap in the proteins involved or the relationships described.",p(HGNC:SLAMF1),directlyIncreases,p(HGNC:TICAM2),p(HGNC:TRAM1),partOf,"complex(p(HGNC:SLAMF1), p(HGNC:TRAM1))",False,False,False,True,True,0.3416666666666667,Secondary Match
19,We found that endogenous SLAMF1 protein interacted with TRAM and defined key interaction domains as amino acids 68 to 95 of TRAM as well as 15 C-terminal amino acids of SLAMF1.,"complex(p(HGNC:SLAMF1), p(HGNC:TICAM2))",,,,"complex(p(HGNC:SLAMF1), p(HGNC:TICAM2))",,,,,,False,False,False,False,False,0.0,LLM Only
20,This results in an immediate activation of nuclear factor kappaB (NF-kappaB) and production of proinflammatory cytokines.,p(HGNC:TLR4) directlyIncreases act(p(FPLX:NFkappaB)),,,,p(HGNC:TLR4),directlyIncreases,act(p(FPLX:NFkappaB)),,,,False,False,False,False,False,0.0,LLM Only
20,"TLR4 recognizes lipopolysaccharide (LPS) from Gram-negative bacteria in complex with the coreceptors myeloid differentiation factor 2 and CD14, and it recruits signaling adapters myeloid differentiation primary response gene 88 (MyD88) and MyD88 adapter-like (Mal).","complex(p(HGNC:TLR4), a(CHEBI:lipopolysaccharide), p(HGNC:F2), p(HGNC:CD14))",,,,"complex(p(HGNC:TLR4), a(CHEBI:lipopolysaccharide), p(HGNC:F2), p(HGNC:CD14))",,,,,,False,False,False,False,False,0.0,LLM Only
5,"These results seem contradictory because AKT2 phosphorylated S326, but the level of phosphorylation far exceeded the HSF1 activity induced by AKT2 (Fig. 1A-D).",,"a(TEXT:""Fig. 1A-D"") increases p(HGNC:5224 ! HSF1)",INDRA Only,,,,,"a(TEXT:""Fig. 1A-D"")",increases,p(HGNC:HSF1),False,False,False,False,False,0.0,INDRA Only
19,"In this study, we report that SLAMF1 is required for Toll-like receptor 4 (TLR4)-mediated induction of interferon beta (IFNbeta) and for killing of Gram-negative bacteria by human macrophages.",,p(HGNC:11850 ! TLR4) increases p(FPLX:IFNB ! IFNB),INDRA Only,,,,,p(HGNC:TLR4),increases,p(FPLX:IFNB),False,False,False,False,False,0.0,INDRA Only
